Alexion Access Foundation is located in New Haven, CT. The organization was established in 2008. According to its NTEE Classification (E60) the organization is classified as: Health Support, under the broad grouping of Health Care and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alexion Access Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Alexion Access Foundation generated $121.6m in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 38.6% each year . All expenses for the organization totaled $121.5m during the year ending 12/2022. While expenses have increased by 38.5% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2020, Alexion Access Foundation has awarded 13 individual grants totaling $218,053,147. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
Part 3 - Line 4a
PROVIDES CERTAIN ALEXION PRODUCTS AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD PRESCRIBED PRODUCTS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Eric Rogers President/director | 0.5 | $0 | |
Tamar Thompson Director | 0.5 | $0 | |
Isabel Firmino Director | 0.5 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Sidley Austin Llp | 12/30/22 | $225,701 |
Foley Hoag | 12/30/22 | $152,545 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $121,591,855 |
Interest on Savings | $0 |
Dividends & Interest | $0 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $0 |
Capital Gain Net Income | $0 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $121,591,855 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $0 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $0 |
Interest | $0 |
Taxes | $0 |
Depreciation | $0 |
Occupancy | $0 |
Travel, conferences, and meetings | $270 |
Printing and publications | $0 |
Other expenses | $31,760 |
Total operating and administrative expenses | $423,401 |
Contributions, gifts, grants paid | $121,111,855 |
Total expenses and disbursements | $121,535,256 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $132,567 |
Savings and temporary cash investments | $0 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $0 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $0 |
Other assets | $0 |
Total assets | $132,567 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Over the last fiscal year, Alexion Access Foundation has awarded $121,111,855 in support to 5 organizations.
Grant Recipient | Amount |
---|---|
VIALS OF STRENSIQ WERE DISTRIBUTED PURPOSE: PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | $42,380,052 |
VIALS OF SOLIRIS WERE DISTRIBUTED T PURPOSE: PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | $42,164,672 |
VIALS OF ULTOMIRIS WERE DISTRIBUTED PURPOSE: PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | $27,865,936 |
VIALS OF KOSELUGO WERE DISTRIBUTED PURPOSE: PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | $4,780,555 |
VIALS OF KANUMA WERE DISTRIBUTED TO PURPOSE: PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | $3,920,640 |